Literature DB >> 1938615

Isolation of a bromo analog of rebeccamycin from Saccharothrix aerocolonigenes.

K S Lam1, D R Schroeder, J M Veitch, J A Matson, S Forenza.   

Abstract

When grown in a defined medium containing 0.05% KBr, Saccharothrix aerocolonigenes ATCC 39243 produces a novel bromo analog of rebeccamycin. This new analog, designated bromorebeccamycin, has been isolated from the culture broth and purified by vacuum liquid chromatography and column chromatography. Spectroscopic data demonstrated that bromorebeccamycin has the same structure as rebeccamycin, except for the replacement of the two chlorine atoms by bromine atoms in the molecule. Bromorebeccamycin and rebeccamycin have a similar potency and activity against P388 leukemia in the murine model.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1938615     DOI: 10.7164/antibiotics.44.934

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  6 in total

Review 1.  Astonishing diversity of natural surfactants: 6. Biologically active marine and terrestrial alkaloid glycosides.

Authors:  Valery M Dembitsky
Journal:  Lipids       Date:  2005-11       Impact factor: 1.880

2.  Cytotoxic Indolocarbazoles from Actinomadura melliaura ATCC 39691.

Authors:  Khaled A Shaaban; Sherif I Elshahawi; Xiachang Wang; Jamie Horn; Madan K Kharel; Markos Leggas; Jon S Thorson
Journal:  J Nat Prod       Date:  2015-06-19       Impact factor: 4.050

3.  Combinatorial biosynthesis of antitumor indolocarbazole compounds.

Authors:  César Sánchez; Lili Zhu; Alfredo F Braña; Aaroa P Salas; Jürgen Rohr; Carmen Méndez; José A Salas
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-29       Impact factor: 11.205

4.  Robust in vitro activity of RebF and RebH, a two-component reductase/halogenase, generating 7-chlorotryptophan during rebeccamycin biosynthesis.

Authors:  Ellen Yeh; Sylvie Garneau; Christopher T Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-02       Impact factor: 11.205

Review 5.  Engineering biosynthetic pathways to generate antitumor indolocarbazole derivatives.

Authors:  César Sánchez; Carmen Méndez; José A Salas
Journal:  J Ind Microbiol Biotechnol       Date:  2006-02-21       Impact factor: 3.346

Review 6.  Natural products for cancer chemotherapy.

Authors:  Arnold L Demain; Preeti Vaishnav
Journal:  Microb Biotechnol       Date:  2010-11-18       Impact factor: 5.813

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.